Introduction
============

Uterine leiomyomas are benign monoclonal tumors that originate from the smooth muscle of the uterus. Although 70% of uterine leiomyomas are asymptomatic, they can cause dysmenorrhea, menorrhagia, infertility, abortion, pelvic pressure and pain. Symptoms depend on the location and size of the uterine leiomyomas, although not in all cases [@R5911751-1] .

Pelvic pain is a relatively common and important clinical symptom. Clinical studies have reported pelvic pain complaints in about 34% of patients with uterine leiomyoma [@R5911751-2] . The most commonly used scale for evaluating subjective pain is the "visual analog scale (VAS)". Patients rate the pain by giving it a score between 0 and 10 (i.e., from none to severe) [@R5911751-3] . We used this scale in the present study.

Endometriosis and uterine leiomyomas are common causes of pelvic pain. Increased nerve fibers in the endometrium have been detected in a majority of patients with endometriosis in some studies [@R5911751-4] ,  [@R5911751-5] . Because adenomyosis and uterine leiomyomas are believed to be controlled by the same steroid hormones as endometriosis, it was suggested that increased nerve fibers may be involved in the mechanism of pain generation in women with uterine leiomyomas. So far, only two studies have investigated the density of nerve fibers in the endometrium and myometrium of patients with endometriosis, adenomyosis and uterine leiomyomas with pain [@R5911751-6] ,  [@R5911751-7] . These studies retrospectively evaluated nerve fibers in the endometrium and myometrium, but not in leiomyoma tissue, and found increased nerve fibers in patients reporting pain.

Protein Gene Product 9.5 (PGP 9.5) is a specific marker for both myelinated and unmyelinated nerve fibers and neurofilament (NF) is a specific marker for unmyelinated nerve fibers [@R5911751-8] . We used these dyes as biological neuronal markers to detect nerve fibers in tissue, as was also done in the majority of studies in the literature.

A better understanding of the physiopathology of pain and its relationship to nerve fibers in uterine leiomyomas could contribute to better therapeutic management. For this reason, we aimed to prospectively compare the presence and density of nerve fibers in patients with or without pain.

Methods
=======

Participants and study design
-----------------------------

Premenopausal women between the ages of 40 -- 50 undergoing hysterectomy for uterine leiomyoma were recruited prospectively into the study. The indications for hysterectomy included enlarged uterus, chronic pelvic pain, pelvic pressure symptoms, intractable menorrhagia or dysmenorrhea. The exclusion criteria were psychiatric or neurological disorders, disease that can alter the perception of pain (diabetes mellitus, etc.), hormone treatment for at least 6 months prior to surgery, and the presence of other gynecological diseases (adnexal masses, endometrioma, endometriosis, pelvic congestion syndrome, etc.). The study was approved by the Dr. Lutfi Kirdar Kartal Training and Research Hospital Ethical Committee (approval number: 89513307/1009/351). Oral and written informed consent was obtained from all patients scheduled for hysterectomy because of uterine leiomyoma who agreed to participate in the study.

The sample size was calculated on the basis of a previous study conducted by Zhang et al., which had reported a 69% difference in nerve fiber density between patients with and patients without pain [@R5911751-6] . Based on their findings, it was estimated that 12 patients would have to be included into each group to achieve a 69% difference between two groups with 0.05 alpha error and 95% power.

The visual analog scale (VAS) was used to measure pain levels before surgery. The VAS scale was administered to all patients by the same physician. Forty-eight patients were prospectively included in the study; 25 patients with leiomyoma without pelvic pain (VAS \< 5) were assigned into Group 1, 23 patients with leiomyoma and pelvic pain (VAS ≥ 5) were assigned into Group 2.

Collection of tissue samples
----------------------------

The tissue samples were obtained from the endometrium, myometrium and uterine leiomyoma. The number and density of myelinated and unmyelinated nerve fibers were investigated using Protein Gene Product 9.5 (PGP 9.5) and neurofilament (NF) staining ( [Figs. 1](#FI5911751-1){ref-type="fig"} and [2](#FI5911751-2){ref-type="fig"} ).

![ Nerve fibers in fibroid tissue (× 200, PGP 9.5). Tissue samples were obtained from uterine leiomyoma. The density and number of nerve fibers were investigated with Protein Gene Product 9.5 (PGP 9.5) staining.](10-1055-a-0591-1751-i5911751gf01){#FI5911751-1}

![ Nerve fibers in fibroid tissue (× 200, NF). Tissue samples were obtained from uterine leiomyoma. The density and number of nerve fibers were investigated with neurofilament (NF) staining.](10-1055-a-0591-1751-i5911751gf02){#FI5911751-2}

Histopathological examination
-----------------------------

Formalin-fixed paraffin-embedded tissue samples were incubated for 30 minutes with rabbit polyclonal Anti-PGP 9.5 (CELL MARQUE, Code CMC 31811021, 1/200 dilution, USA) or Anti-neurofilament (2F11) mouse monoclonal antibody (CELL MARQUE, Code CMC 30221021, 1/200 dilution, USA). Post-primary antibody, polymer antibody and diaminobenzidine (DAB) were added, respectively. Paraffin sections were stained using Mayerʼs hematoxylin. All samples were evaluated by the same pathologist using an Olympus BX53 microscope. The diagnosis of uterine leiomyoma was confirmed in all patients by histopathologic examination.

Statistical analysis
--------------------

Data were analyzed using SPSS version 22.0. Mean standard deviation, median (lowest and highest), frequency and ratio values were used for descriptive statistics. Histogram, normality plots and Shapiro-Wilk normality test were used to analyze data distribution. Mann-Whitney U test was used to analyze quantitative data. χ ^2^ test or Fisherʼs exact test was used to analyze qualitative data. Cohenʼs kappa coefficient was used to measure agreement between the two staining techniques. Statistical significance was established at p \< 0.05.

Results
=======

Demographic data
----------------

There were no statistically significant differences between the two groups with regard to age, number of pregnancies, and size and location of uterine leiomyomas. There was a statistically significant difference between groups with regard to VAS pain scores and duration of pain (p \< 0.05) ( [Table 1](#TB5911751-1){ref-type="table"} ).

###### 

**Table 1**  Patient demographics.

                                          Group 1 (n = 25)   Group 2 (n = 23)   p
  --------------------------------------- ------------------ ------------------ --------------
  Age (years)                             47 ± 2.86          46.21 ± 3.27       0.06
  Gravida                                 3 (1 -- 11)        3 (1 -- 7)         0.63
  Size of uterine fibroid (cm)            7.68 ± 4.02        8.91 ± 4.99        0.53
  Duration of pain (months)               2 (0 -- 24)        12 (2 -- 72)       **\< 0.005**
  VAS (visual analog scale) pain scores   2 (0 -- 4)         7 (6 -- 8)         **\< 0.005**

Endometrial samples
-------------------

None of the endometrial samples from either of the groups stained with PGP 9.5 or NF. The distance of nerve fibers to the endometrial lining was similar in both groups (p \> 0.05).

Myometrial samples
------------------

The percentage of nerve fibers stained with PGP 9.5 in myometrial tissue was 84% (n = 21) in Group 1 and 70% (n = 16) in Group 2 (p = 0.23). The percentage of nerve fibers stained with NF in myometrial tissue was 88% (n = 22) in Group 1 and 74% (n = 17) in Group 2 (p = 0.28). The density of nerve fibers stained with PGP 9.5 in myometrial tissue was 0.1 ± 0.22 per mm ^2^ in Group 1 and 0.1 ± 0.21 per mm ^2^ in Group 2 (p = 0.39). The density of nerve fibers stained with NF in myometrial tissue was 0.06 ± 0.09 per mm ^2^ in Group 1 and 0.07 ± 0.12 per mm ^2^ in Group 2 (p = 0.83). There was no statistically significant difference between the two groups ( [Table 2](#TB5911751-2){ref-type="table"} ).

###### 

**Table 2**  Comparison of presence and density of nerve fibers between groups.

                                                              PGP 9.5         p               NF        p                               
  ----------------------------------------------------------- --------------- --------------- --------- --------------- --------------- ---------
  Presence of nerve fibers in endometrium                     --              --                        --              --              
  Presence of nerve fibers in myometrial tissue (%)           84              70              0.23      88              74              0.28
  Density of nerve fibers in myometrial tissue (per mm ^2)^   0.1 ± 0.22      0.1 ± 0.21      0.39      0.06 ± 0.09     0.07 ± 0.12     0.83
  Density of nerve fibers in fibroid tissue (per mm ^2)^      0.001 ± 0.006   0.001 ± 0.003   0.29      0.004 ± 0.013   0.002 ± 0.007   0.65
  Percentage of nerve fibers in uterine fibroid tissue (%)    4 (n = 1)       13 (n = 3)      \> 0.05   12 (n = 3)      9 (n = 2)       \> 0.05

Leiomyoma tissue samples
------------------------

The percentage of nerve fiber tissue stained with PGP 9.5 in uterine leiomyoma tissues was 4% (n = 1) in Group 1 and 13% (n = 3) in Group 2 (p \> 0.05). The percentage of nerve fiber tissue stained with NF in uterine leiomyoma tissues was 12% (n = 3) in Group 1 and 9% (n = 2) in Group 2 (p \> 0.05). The density of nerve fibers stained with PGP 9.5 in uterine leiomyoma tissues was 0.001 ± 0.06 per mm ^2^ in Group 1 and 0.001 ± 0.003 per mm ^2^ in Group 2 (p = 0.29). The density of nerve fibers stained with NF in uterine leiomyoma tissues was 0.004 ± 0.013 per mm ^2^ in Group 1 and 0.002 ± 0.007 per mm ^2^ in Group 2 (p = 0.65). There was no statistically significant difference between the two groups ( [Table 2](#TB5911751-2){ref-type="table"} ).

When we look at the consistency between the two dyeing methods, nerve fibers in uterine leiomyoma tissues showed fair agreement (p \< 0.05/κ = 0.388) and nerve fibers in myometrial tissues showed substantial agreement (p \< 0.05/κ = 0.622). The distribution of nerve fibers in myometrial and leiomyoma tissue was similar in both groups with both dyes.

Discussion
==========

Physiologically, uterine innervation is regulated by estrogen and progesterone through neurotrophins (nerve growth factor, prostaglandins, etc.) [@R5911751-9] ,  [@R5911751-10] . In estrogen-dependent diseases such as endometriosis, adenomyosis and uterine leiomyoma, estrogen may play a role in the increase of nerve fibers in the endometrium and myometrium by regulating neurotrophins. It is known that there are no nerve fibers in the functional layer of the endometrium. In recent years, however, many publications have identified nerve fibers in endometrial specimens of endometriosis patients who present with pain complaints [@R5911751-5] ,  [@R5911751-6] ,  [@R5911751-11] , [@R5911751-12] , [@R5911751-13] . Based on these findings, we thought that investigating the presence of nerve fibers in uterine leiomyoma patients could shed light on the etiopathogenesis of leiomyoma-associated pain.

There is only one study on the innervation of endometrial and myometrial tissue in patients with painful uterine leiomyomas [@R5911751-7] . In this study, the density of PGP 9.5-stained nerve fibers was significantly higher in the functional and basal layer of the endometrium in patients with uterine leiomyoma and pain complaint. According to the authors, nerve fibers in the functional layer of the endometrium could play a role in the pathogenesis of pain in patients with endometriosis, adenomyosis and uterine leiomyomas with pain complaint. In contrast to their results, in our study nerve fibers could not be detected in endometrial tissue of any of the patients using PGP 9.5 and NF dye. The absence of nerve fibers in the endometrium may be due to endometrial compression atrophy associated with large uterine leiomyomas (mean size: 8.27 ± 4.50 cm) in our study group.

In recent years, several studies have indicated that the amount of nerve fibers in the myometrium of patients with pelvic pain is higher than in patients without pain [@R5911751-14]  --  [@R5911751-16] . Lerner and his co-workers reported on the proliferation and hypertrophy of unmyelinated nerve fibers in the myometrium of patients with chronic pelvic pain [@R5911751-13] . In another study, nerve fiber proliferation was detected in myometrial tissue around the arteries and veins of patients with endometriosis-associated dysmenorrhea and dyspareunia [@R5911751-15] . Sun et al. investigated increased nerve fiber density in pseudo-capsules using staining with anti-oxytocin and PGP 9.5 and compared the result to findings for the adjacent myometrium. However they did not compare the nerve fiber density of patients with and patients without pain [@R5911751-17] . Their findings indicate that pelvic pain could be correlated with increased myometrial nerve fibers. In our study, nerve fibers in the myometrium stained with PGP 9.5 and NF were detected in 77 and 81% of all patients, respectively. But there was no significant difference between patients with and patient without pain with regard to nerve fiber density in myometrial tissue detected by staining with PGP 9.5 (p = 0.39) and NF (p = 0.83).

In the literature the only study related to innervation in leiomyomas is a retrospective qualitative study which demonstrated that leiomyomas in multiparous women do not contain nerves while leiomyomas in nulliparous women contain nerves [@R5911751-18] . We investigated the density of nerve fibers in uterine leiomyoma tissue. Nerve fibers stained with PGP 9.5 and NF in leiomyoma tissue were detected in 8 and 10% of patients, respectively. We found that there was no significant difference between patients with and patients without pain in terms of nerve fiber density in uterine leiomyoma tissue based on staining with PGP 9.5 (p = 0.29) and NF (p = 0.65).

The diagnosis of uterine leiomyoma was confirmed in all patients by histopathologic examination. The strength of this study which investigated nerve fiber density in uterine leiomyoma tissue, endometrial and myometrial tissue was its prospective design and quantitative approach. To the best of our knowledge, the current study is the first quantitative study investigating nerve fiber density in uterine leiomyoma tissue. The relatively small sample size can be viewed as a limitation.

In conclusion, the mechanisms of dysmenorrhea and pelvic pain in patients with uterine leiomyoma are not yet fully understood. In our study, NF and PGP 9.5 immunoreactive-staining nerve fibers were not detected in the endometrium of any patients with uterine leiomyoma and pain complaint. The quantity and density of nerve fibers in myometrial and leiomyoma tissue in patients with pain was similar to that detected in patients without pain. A population-based study is needed to investigate the mechanism of pain in uterine leiomyomas.
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